E-LIB Suche - Ergebnisse für: Leav, Brett A

1

Coronavirus Disease 2019 Vaccine Efficacy in Participants W..:

Sherman, Amy C ; Tuan, Jessica ; Cantos, Valeria D...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

No immunological interference or concerns about safety when..:

Naficy, Abdi ; Kuxhausen, Adrienne ; Seifert, Harry...
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

Safety and immunogenicity of a third dose of mRNA‐1273 vacc..:

Giuliano, Anna ; Kuter, Barbara ; Pilon‐Thomas, Shari...
Cancer Communications. 43 (2023) 7 - p. 749-764 , 2023

Link: https://doi.org/10.1002/..

4

Stochastic interventional approach to assessing immune corr..:

Hejazi, Nima S. ; Shen, Xiaoying ; Carpp, Lindsay N....
International Journal of Infectious Diseases. 137 (2023) - p. 28-39 , 2023

Link: https://doi.org/10.1016/..

5

Neutralizing Antibody Response following a Third Dose of th..:

Dukes, Christopher W. ; Potez, Marine ; Lancet, Jeffrey...
Vaccines. 12 (2023) 1 - p. 13 , 2023

Link: https://doi.org/10.3390/..

6

The safety and immunogenicity of two Zika virus mRNA vaccin..:

Essink, Brandon ; Chu, Laurence ; Seger, William...
The Lancet Infectious Diseases. 23 (2023) 5 - p. 621-633 , 2023

Link: https://doi.org/10.1016/..

7

Risk of COVID-19 after natural infection or vaccination:

Rick, Anne-Marie ; Laurens, Matthew B. ; Huang, Ying...
eBioMedicine. 96 (2023) - p. 104799 , 2023

Link: https://doi.org/10.1016/..

8

Lessons From COVID-19 for Pandemic Preparedness: Proceeding..:

Narayanasamy, Shanti ; Curtis, Lesley H ; Hernandez, Adrian F...
Clinical Infectious Diseases. 77 (2023) 12 - p. 1635-1643 , 2023

Link: https://doi.org/10.1093/..

9

No Immunological Interference or Safety Concerns When Adjuv..:

Naficy, Abdi ; Kuxhausen, Adrienne ; Pirrotta, Paola...
Clinical Infectious Diseases. 77 (2023) 9 - p. 1238-1246 , 2023

Link: https://doi.org/10.1093/..

10

Modifiers of COVID-19 vaccine efficacy: Results from four C..:

Turley, Christine B. ; Tables, LaKesha ; Fuller, Trevon...
Vaccine. 41 (2023) 33 - p. 4899-4906 , 2023

Link: https://doi.org/10.1016/..

11

Immune response to SARS-CoV-2 after a booster of mRNA-1273:..:

Chu, Laurence ; Vrbicky, Keith ; Montefiori, David...
Nature Medicine. 28 (2022) 5 - p. 1042-1049 , 2022

Link: https://doi.org/10.1038/..

12

A Brighton Collaboration standardized template with key con..:

Leav, Brett ; Straus, Walter ; White, Phil...
Vaccine. 40 (2022) 35 - p. 5275-5293 , 2022

Link: https://doi.org/10.1016/..

13

Safety, immunogenicity and antibody persistence of a bivale..:

Chalkias, Spyros ; Eder, Frank ; Essink, Brandon...
Nature Medicine. 28 (2022) 11 - p. 2388-2397 , 2022

Link: https://doi.org/10.1038/..

14

Initial analysis of viral dynamics and circulating viral va..:

Pajon, Rolando ; Paila, Yamuna D. ; Girard, Bethany...
Nature Medicine. 28 (2022) 4 - p. 823-830 , 2022

Link: https://doi.org/10.1038/..

15

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phas..:

El Sahly, Hana M ; Baden, Lindsey R ; Essink, Brandon...
The Journal of Infectious Diseases. 226 (2022) 10 - p. 1731-1742 , 2022

Link: https://doi.org/10.1093/..